Are loopholes endangering Poland’s healthcare?

Add bookmark
As Poland announces plans to create a British-style NHS, a recent paper has proposed that one priority should be to address the potential blurred boundaries between public bureaucracies, politicians and industry providers such as pharmaceutical companies.Although the EU controls the approval process for new medicines, individual member states decide which to prioritise and subsidise. Research published in the British Journal of Sociology suggests that Poland’s pricing and reimbursement poli...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended